
April to June 2023
| Drug Name | Government Contribution Dollars | Prescriptions |
|---|---|---|
| ELEXACAFTOR + TEZACAFTOR + IVACAFTOR (&) IVACAFTOR | $141,190,296 | 6,609 |
| MOLNUPIRAVIR | $130,774,870 | 115,491 |
| PEMBROLIZUMAB | $118,409,265 | 13,882 |
| NIVOLUMAB | $112,793,282 | 15,673 |
| AFLIBERCEPT | $101,387,608 | 103,071 |
| USTEKINUMAB | $97,763,806 | 13,269 |
| NIRMATRELVIR (&) RITONAVIR | $96,112,142 | 82,202 |
| APIXABAN | $78,512,749 | 994,676 |
| DUPILUMAB | $74,444,518 | 43,386 |
| DENOSUMAB | $73,701,199 | 293,389 |
| SEMAGLUTIDE | $65,238,394 | 554,627 |
| ADALIMUMAB | $58,132,767 | 81,241 |
| Drug Name | Government Contribution Dollars | Prescriptions |
|---|---|---|
| ROSUVASTATIN | $25,526,913 | 4,330,296 |
| ATORVASTATIN | $20,472,484 | 3,103,470 |
| PANTOPRAZOLE | $17,680,243 | 2,628,038 |
| ESOMEPRAZOLE | $16,208,557 | 2,088,711 |
| PERINDOPRIL | $10,660,633 | 1,815,594 |
| ESCITALOPRAM | $5,970,201 | 1,565,393 |
| METFORMIN | $10,064,886 | 1,484,610 |
| SERTRALINE | $6,178,336 | 1,462,650 |
| AMOXICILLIN | $4,635,555 | 1,351,699 |
| AMLODIPINE | $7,708,359 | 1,252,867 |
| CEFALEXIN | $5,595,195 | 1,227,714 |
| TELMISARTAN | $6,383,731 | 1,164,317 |
| Contributor | Contribution Dollars |
|---|---|
| Australian Government | $4,181,012,976 |
| Patients | $898,991,969 |